Generate a tailored SOP for Dr. Jill De Jong. Improve your application with a focused, well-structured draft.
Dr. Jill De Jong is an Associate Professor in the Department of Pediatrics at the University of Chicago. She has specialized expertise in pediatric hematology and oncology, particularly in the treatment of children with various cancer and blood disorders. Her clinical interests include anemias, autoimmune blood diseases, benign hematology, bleeding disorders, CAR T-cell therapy, and childhood cancers. Dr. De Jong serves as the director of Pediatric Hematology and is co-director of the Pediatric Cancer Genetic Risk clinic and the Pediatric Bone Marrow Failure clinic. Her research focuses on understanding the genetic risks associated with hematopoietic malignancies and the genetic causes of aplastic anemia. She has contributed significantly to evidence-based recommendations for treating severe aplastic anemia in children. Dr. De Jong has published numerous articles in leading medical journals and is recognized with several awards, including the Pritzker Scholar Award and membership in the Alpha Omega Alpha Medical Honor Society.
University of Chicago • Chicago, IL
Leading pediatric hematology services, focusing on blood disorders and genetic risks.
Department of Philosophy